National cancer grid

•Download as PPTX, PDF•

1 like•150 views

Manjunath GN

Brief description about the purpose and functions of National cancer Grid - an initiative by Tata memorial horpital

Cancer burden in India
New cancer patients
diagnosed every year
2012 10 lakhs
2035(predicted) 17 lakhs
Statistics: GLOBOCAN 2012

Cancer deaths in India
Cancer related deaths
per year
2012 6.5 lakhs
2035(predicted) 12 lakhs
Statistics: GLOBOCAN 2012

Proportion of Cancer deaths
Cancer deaths /
Incidence
India 6.8
Developed
countries
3.5 to 5.7
Statistics: GLOBOCAN 2012

High proportion of cancer
deaths in india is due to
1. Advanced stage at presentation
2. Lack of cancer care facilities
3. Unaffordability of treatment
4. Lack of trained personnel
5. Lack of unified strategy
6. Lack of research - india specific
problems

National Cancer Grid
was established specifically to adress
Points 4, 5 & 6

The National Cancer Grid
» NCG is a network of major cancer centers, research
institutes, patient groups and charitable institutions
across India.
» NCG was formed in August 2012.
» Funded by Govt of INDIA

The National Cancer Grid
» Its Purpose is to establish
1. Uniform standards of patient care for prevention,
diagnosis, & treatment of cancer.
2. Providing specialized training and education in
oncology.
3. Facilitating collaborative basic, translational and
clinical research in cancer.

The National Cancer Grid
» Largest network of cancer hospitals in the world.
» At present has 140 member institutions.

Functions of NCG
Patient
Care
Collaborativ
e research
Education
and
Training

Patient Care
» Formulation of evidence-based management
guidelines for common cancers.
» Systematic method of data capture of every patient
being treated at a cancer center.
» Voluntary process of audit & peer review of
institutions.

Education and Training
» “National Cancer Library” - free access of high-
quality cancer journals and other educational
resources to the constituent centers.
» Exchange of expertise & mentoring between the
centers.
» Training of cadres of physicians and paramedical
staff

Travelling school of pathology
» Workshops conducted in member institutions
about quality surgical pathology reporting.

Collaborative research
» Establish research networks (like RTOG &
ESMO), which facilitate high-quality
multicentric cancer research aimed at
addressing India's unique problems.

Long term goal
» Formulating National cancer policy

Place your screenshot here
How to join NCG
Joining NCG is a simple
procedure - Application forms
available at
https://tmc.gov.in/ncg/home

We can benifit
&
We can contribute
by joining national cancer grid

1. https://tmc.gov.in/ncg/index.php
2. C. S. Pramesh, Rajendra A. Badwe & Ratan Kumar Sinha.
The National Cancer Grid of India. Indian J Med Paediatr
Oncol. 2014 Jul-Sep; 35(3): 226–227.
Refrences

What's hot

Chapter 34 medical stat

Nilesh Kucha

LHRH agonist vs antagonist in prostate cancer

Alok Gupta

Radiation Oncology Slides 2003 1203

Ahamed Badusha

Landmark trials in carcinoma breast

Stalinsurgeon Joseph Antonymuthu

MANAGEMENT OF EARLY STAGE NON SMALL CELL LUNG CARCINOMA

Isha Jaiswal

Oligometastases

Cancer surgery By Royapettah Oncology Group

O. Glehen - HIPEC in colorectal carcinomatosis

Glehen

IMRT and 3D CRT in cervical Cancers

Santam Chakraborty

Clinical aspects and applications of high dose-rate brachytherapy

Teresa Muñoz Migueláñez

The principles of head and neck PET/CT

Dr- Mustafa Ahmed Alazam

Brachytherapy in breast cancer

Sarthak Moharir

Cytoreductive nephrectomy (when and why)

Ahmad Kharrouby

CINV (chemotherapy induced nausea & vomiting)

Mohamed Abdulla

Lung sbrt ppt

Dr. Rituparna Biswas

PENILE CONSERVATION BY RADIOTHERAPY

Kanhu Charan

MANAGEMENT OF TRIPLE NEGATIVE BREAST CANCER.pptx

Cancer surgery By Royapettah Oncology Group

Chapter 39 role of radiotherapy in benign diseases.pptx [read only]

Nilesh Kucha

Maxilla

Nilesh Kucha

$Hypofractionation in breast cancer$ $Hypofractionation in breast cancer$

Hypofractionation in breast cancer

National Cancer Institute, AIIMS, New Delhi, India

Embrace ii protocol

GloribelBolvar1

What's hot (20)

Chapter 34 medical stat

LHRH agonist vs antagonist in prostate cancer

Radiation Oncology Slides 2003 1203

Landmark trials in carcinoma breast

MANAGEMENT OF EARLY STAGE NON SMALL CELL LUNG CARCINOMA

Oligometastases

O. Glehen - HIPEC in colorectal carcinomatosis

IMRT and 3D CRT in cervical Cancers

Clinical aspects and applications of high dose-rate brachytherapy

The principles of head and neck PET/CT

Brachytherapy in breast cancer

Cytoreductive nephrectomy (when and why)

CINV (chemotherapy induced nausea & vomiting)

Lung sbrt ppt

PENILE CONSERVATION BY RADIOTHERAPY

MANAGEMENT OF TRIPLE NEGATIVE BREAST CANCER.pptx

Chapter 39 role of radiotherapy in benign diseases.pptx [read only]

Maxilla

$Hypofractionation in breast cancer$ $Hypofractionation in breast cancer$

Hypofractionation in breast cancer

Embrace ii protocol

Similar to National cancer grid

GO_Strategic_Framework_2016Ian Manger

Joining forces to overcome cancer by izaq odongo

Kesho Conference

Cancer control program

pramod kumar

Day 2 Speaker Presentation - Françoise Cluzeau

Tropical Health and Education Trust

ICICI Direct IPO note on Healthcare Global Enterprises

Ketandhad

Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx

aryan532920

Running Head: Colorectal Cancer Prevention Program-Evaluation Design 9 Colorectal Cancer Prevention Program Evaluation Design Kaplan University-PU630-Unit 7 September 20, 2016 Deserie Thomas Dr. Amy Thompson COLORECTAL CANCER PREVENTION PROGRAM EVALUATION DESIGN Engaged Stakeholders What Stakeholders Want to Know Public Health Department Document the resources that have been leveraged to support colorectal cancer prevention program efforts. Local Legislators Identify the number of people receiving services and the extent to which interventions are yielding intended awareness, behavioral and/or health outcomes for participants. Intervention participants Determine the extent to which interventions are yielding intended awareness, behavioral and/or health outcomes for participants. Community Clinic Review the quality, contributions, and impact of the Colorectal Cancer Coalition. Review the quality and implementation progress of the statewide Colorectal Cancer Coalition plan. Determine to what extent interventions outlined in the Colorectal Cancer Coalition action plan are being executed and yielding intended results. Local American Cancer Society Partner Determine whether American Cancer Society products are being incorporated effectively into the efforts of the colorectal cancer prevention program. Engaging Stakeholders Health Department Members of the evaluation advisory committee Presenters/advocates who share findings with state and community partners All phases of the evaluation process via regular evaluation advisory committee meetings Legislators External reviewers of evaluation plans and methods Evaluation planning phase Intervention Participants Members of the evaluation advisory committee Data sources (i.e., participants in evaluation interviews and surveys) Two representatives to participate in all phases of the evaluation process via regular evaluation advisory committee Community Clinic External reviewers of evaluation plans and methods Evaluation implementation phase Evaluation planning phase Local American Cancer Society Partner Data analysts Presenters/advocates who share findings with state and community partners Evaluation implementation phase Dissemination phase Evaluation Stakeholder Group Composition The composition of the evaluation stakeholders will fund and authorized the continuation or expansion of the Colorectal Cancer Prevention Program. The stakeholders are responsible for day to day implementation of the activities that are part of the program, and has a strong influence on the development of thoughtful evaluation questions that will generate evaluation findings that are useful, relevant, and credible (assuming the evaluation applies the appropriate design and data collection and analysis methods). Ideally, the evaluation stakeholders gro ...

National cancer strategy in qatar 2011 – 2016Dr. Anees Alyafei

About the Ontario Institute for Cancer Research

josephoicr

How Community Engagement Fits Into The Mission Of The National Center for Adv...

SC CTSI at USC and CHLA

Christopher Austin, MD, Director of the National Center for Advancing Translational Sciences (NCATS) shared his thoughts on how community engagement fits into the mission of NCATS at the recent CTSA Community Engagement Key Function Committee (KFC) conference. He proposed a revision of NCATS' mission: "To catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of interventions that tangibly improve human health across a wide range of human diseases and conditions." Learn more about NCATS http://www.ncats.nih.gov/

Csr (1) Cancer Awareness and Screening - Early Detection: Early cure Priya Parmar

1092 (16-17) Operational Framework Management of Common Cancers (1)Mayank Sharma

Paediatric Radiation Oncology: Closing the Gap

Anja Nitzsche-Bell

Operation eyesight

lionsleaders

CCDI Overview November 2022

Warren Kibbe

Ecosystem approaches to the better management of zoonotic emerging infectious...

ILRI

Cancer registry and epidemiology

Purvi Rathod

Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...Sunil Nair

20171021 Cancer prevention in malaysia

R.O.C.Ministry of Health and Welfare

National cancer control programme

anjalatchi

India Cancer Diagnostics Market: Size, Share, and In-Depth Competitive Analys...

Kumar Satyam

According to the TechSci Research report, “India Cancer Diagnostics Market –Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028,” the India Cancer Diagnostics Market stood at USD 571.03 billion in 2022 and is anticipated to grow with a CAGR of 7.36% in the forecast period, 2024-2028. Awareness among individuals regarding cancer diagnostics has led to favorable market conditions for the India Cancer Diagnostics market. Several factors contribute to the growth of various cancer diagnostics products, including advancements in technology, government initiatives, and increased healthcare investments. Market Dynamics Rising Incidence of Cancer In 2022, the projected number of new cancer cases in India was 1,461,427, with a crude incidence rate of 100.4 per 100,000 individuals. Approximately one in nine people in India is expected to face a cancer diagnosis during their lifetime. Notably, lung cancer ranked highest among males, while breast cancer held the top spot for females. Within childhood cancers (0-14 years), lymphoid leukemia emerged as the predominant site, accounting for 29.2% in boys and 24.2% in girls. Looking ahead, an estimated 12.8% increase in cancer incidence by 2025 is expected compared to 2020.

Similar to National cancer grid (20)

GO_Strategic_Framework_2016

Joining forces to overcome cancer by izaq odongo

Cancer control program

Day 2 Speaker Presentation - Françoise Cluzeau

ICICI Direct IPO note on Healthcare Global Enterprises

Running Head Colorectal Cancer Prevention Program-Evaluation Des.docx

National cancer strategy in qatar 2011 – 2016

About the Ontario Institute for Cancer Research

How Community Engagement Fits Into The Mission Of The National Center for Adv...

Csr (1) Cancer Awareness and Screening - Early Detection: Early cure

1092 (16-17) Operational Framework Management of Common Cancers (1)

Paediatric Radiation Oncology: Closing the Gap

Operation eyesight

CCDI Overview November 2022

Ecosystem approaches to the better management of zoonotic emerging infectious...

Cancer registry and epidemiology

Personalized Disease Management - Thyroid Cancer - Knowledge Management - Sun...

20171021 Cancer prevention in malaysia

National cancer control programme

India Cancer Diagnostics Market: Size, Share, and In-Depth Competitive Analys...

Recently uploaded

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Dr Jeenal Mistry

Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol that is rapidly distributed in the body and brain. Ethanol alters many neurochemical systems and has rewarding and addictive properties. It is the oldest recreational drug and likely contributes to more morbidity, mortality, and public health costs than all illicit drugs combined. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) integrates alcohol abuse and alcohol dependence into a single disorder called alcohol use disorder (AUD), with mild, moderate, and severe subclassifications (American Psychiatric Association, 2013). In the DSM-5, all types of substance abuse and dependence have been combined into a single substance use disorder (SUD) on a continuum from mild to severe. A diagnosis of AUD requires that at least two of the 11 DSM-5 behaviors be present within a 12-month period (mild AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria). The four main behavioral effects of AUD are impaired control over drinking, negative social consequences, risky use, and altered physiological effects (tolerance, withdrawal). This chapter presents an overview of the prevalence and harmful consequences of AUD in the U.S., the systemic nature of the disease, neurocircuitry and stages of AUD, comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and pharmacotherapies for AUD.

micro teaching on communication m.sc nursing.pdf

Anurag Sharma

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Dr. Vinay Pareek

How to Give Better Lectures: Some Tips for Doctors

LanceCatedral

Prix Galien International 2024 Forum Program

Levi Shapiro

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Krishan Murari

Evaluation of antidepressant activity of clitoris ternatea in animals

Shweta

Superficial & Deep Fascia of the NECK.pptx

Dr. Rabia Inam Gandapore

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

bkling

Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

DR SETH JOTHAM

The prostate is an exocrine gland of the male mammalian reproductive system It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ). It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes It’s work is regulated by androgens which are responsible for male sex characteristics Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

Savita Shen $i11

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

VarunMahajani

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

greendigital

Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye. Follow us on: Pinterest Introduction Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing . Early Life and Career Childhood and Athletic Beginnings Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle. Transition to Acting Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness. Fitness Regimen Workout Routine Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show. Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles. Importance of Flexibility and Mobility In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

Savita Shen $i11

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

Prof. Marcus Renato de Carvalho

Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva. Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade. Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal. Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural. Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis. É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais. O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada. Recomendamos muito. Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos. Esta publicação só está disponível em inglês até o momento. Prof. Marcus Renato de Carvalho www.agostodourado.com

KDIGO 2024 guidelines for diabetologists

د.محمود نجيب

New Drug Discovery and Development .....

NEHA GUPTA

The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.

heat stroke and heat exhaustion in children

SumeraAhmad5

Recently uploaded (20)

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

micro teaching on communication m.sc nursing.pdf

Physiology of Chemical Sensation of smell.pdf

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

How to Give Better Lectures: Some Tips for Doctors

Prix Galien International 2024 Forum Program

BRACHYTHERAPY OVERVIEW AND APPLICATORS

Evaluation of antidepressant activity of clitoris ternatea in animals

Superficial & Deep Fascia of the NECK.pptx

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf

Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

KDIGO 2024 guidelines for diabetologists

New Drug Discovery and Development .....

heat stroke and heat exhaustion in children

National cancer grid

1. NATIONAL CANCER GRID Dr. MANJUNATH GN Assistant professor Department of Radiation oncology SDUMC, KOLAR

2. Cancer burden in India New cancer patients diagnosed every year 2012 10 lakhs 2035(predicted) 17 lakhs Statistics: GLOBOCAN 2012

3. Cancer deaths in India Cancer related deaths per year 2012 6.5 lakhs 2035(predicted) 12 lakhs Statistics: GLOBOCAN 2012

4. Proportion of Cancer deaths Cancer deaths / Incidence India 6.8 Developed countries 3.5 to 5.7 Statistics: GLOBOCAN 2012

5. High proportion of cancer deaths in india is due to 1. Advanced stage at presentation 2. Lack of cancer care facilities 3. Unaffordability of treatment 4. Lack of trained personnel 5. Lack of unified strategy 6. Lack of research - india specific problems

6. National Cancer Grid was established specifically to adress Points 4, 5 & 6

7. The National Cancer Grid » NCG is a network of major cancer centers, research institutes, patient groups and charitable institutions across India. » NCG was formed in August 2012. » Funded by Govt of INDIA

8. The National Cancer Grid » Its Purpose is to establish 1. Uniform standards of patient care for prevention, diagnosis, & treatment of cancer. 2. Providing specialized training and education in oncology. 3. Facilitating collaborative basic, translational and clinical research in cancer.

9. The National Cancer Grid » Largest network of cancer hospitals in the world. » At present has 140 member institutions.

10. Functions of NCG Patient Care Collaborativ e research Education and Training

11. Patient Care » Formulation of evidence-based management guidelines for common cancers. » Systematic method of data capture of every patient being treated at a cancer center. » Voluntary process of audit & peer review of institutions.

12. Education and Training » “National Cancer Library” - free access of high- quality cancer journals and other educational resources to the constituent centers. » Exchange of expertise & mentoring between the centers. » Training of cadres of physicians and paramedical staff

13. Travelling school of pathology » Workshops conducted in member institutions about quality surgical pathology reporting.

14. Collaborative research » Establish research networks (like RTOG & ESMO), which facilitate high-quality multicentric cancer research aimed at addressing India's unique problems.

15. Long term goal » Formulating National cancer policy

16. Place your screenshot here How to join NCG Joining NCG is a simple procedure - Application forms available at https://tmc.gov.in/ncg/home

17. We can benifit & We can contribute by joining national cancer grid

18. 1. https://tmc.gov.in/ncg/index.php 2. C. S. Pramesh, Rajendra A. Badwe & Ratan Kumar Sinha. The National Cancer Grid of India. Indian J Med Paediatr Oncol. 2014 Jul-Sep; 35(3): 226–227. Refrences

19. Thank you

National cancer grid

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to National cancer grid

Similar to National cancer grid (20)

Recently uploaded

Recently uploaded (20)

National cancer grid